WCDO - Nadzieja wspólczesnej medycyny - Oxetic Medical system

tel: 32 440-99-88 / 731-161-444

Piśmiennictwo


Adaskaveg J. E., Gilbertson R. L., Basidiospores, Pilocystida, and Other Basidiocarp Characters in Several Species of the Ganoderma lucidum Complex. Mycologia, 1988; 80: 493-507. 2. Arisawa M., et al., Three New lanostanoids from Ganoderma lucidum. J. Nat. Prod., 1986; 49(4): 621-625. 3. Arora D., Mushrooms Demystified. Ten Speed Press, Berkeley, 1986. 4. Bao X. F., et al., Structure and Conformation of a Glucan from Spores of Ganoderma lucidum (Fr.) Karst. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 2000; 32(6): 557-561. 5. Bao X., et al., Structural Characterization and Immunomodulating Activity of a Complxs Glucan from Spores Ganoderma lucidum. Biosci. Biotechnol. Biochem., 2001; 65(11): 2384-2391. 6. Bao X., et al., Structural and Immunological Studies of a Major Polysaccharide from Pores of Ganoderma lucidum (Fr.) Karst. Carbohydr. Res., 2001; 332(1): 67-74. 7. Bao X., et al., Chemical Modifications of the (1-3)-alpha-D-glucan from Spores of Ganoderma lucidum and Investigation of their Physicochemical Properties and Immunological Activity. Carbohydr. Res., 2001; 336(2): 127-240. 8. Bao X. F., Fang J. N., Studies on Difference between Sporaderm-broken and nonbroken Spores of Ganoderma lucidum (Leyss ex Fr.) Karst. by Polysaccharide Analysis. Zhongguo Zhong Yao Za Zhi, 2001; 26(5): 326-328. 9. Bao X. F., et al., Structural Features of Immunologically Active Polysaccharides from Genoderma lucidum. Phytochemistry, 2002; 59(2): 175-181 10. Bao X. F., et al., Purification, Characterization, and Modification of T Lymphocyte-stimulating Polysaccharides from Spores of Ganoderma lucidum. Chem. Pharm. Bull, 2002; 50(5): 623-629. 11. Bensky D., Gamble A., Chinese Materia Medica, 2 nd ed. Eastland Press, Seattle, 1993. 12. Berovic M., et al., Submerged Cultivation of Ganoderma lucidum Biomass and Immunostimulatory Effects of Fungal Polysaccharides. J. Biotechnol., 2003; 103(1): 77-86. 13. Brekman I. I, Dardymov I. V., New Substances of Plant Origin which Incease Nonspecific Resistance. Annual Review of Pharmacology, 1969; 419-430. 14. Berger A., et al., Cholesterol-lowering Properties of Ganoderma lucidum in vitro, ex vivo, and in Hamsters and Minipigs. Lipids Health Dis., Feb. 18, 2004 15. Bretsschneider E., Botanicum Sinicum: Notes on Chinese botany from Native and Western Sources. Part I, Journal of the Nort-China Branch of Royal Asiatic Society; 1881; New series;16: (Part one): 224-227. 16. Bretsschneider E., Botanicum Sinicum: Notes on Chinese Botany from Native and Western Sources. Journal of China Branch of Royal Asiatic Society; 1890-1891; New series; 25: 40-41, 194.
17. Bretschneider E., Botanicum Sinicum. Part III. Botanical Investigations into the Materia Medica of the Ancient Chinese. Kelly& Walsh Ltd. Ed., 1895. 18. Bretsschneider E., Botanicum Sinicum: Notes on Chinese botany from Native and Western Sources. Journal of China Branch of Roayl Asiatic Society; 1894-1895; New Series; 29:418-420. 19. Brian P. W., Antibiotics Produced by Fungi. Bot. Rev., 1951; 17: 357-430. 20. Broadbent D., Antibiotics Produced by Fungi. 1966; 32: 219-233. 21. Byun S. H., Kim I. H., Studies on the Concurrent Administration of Medicines VIII. Effects of Concurrent Administration of Ganoderma lucidum Extract and Glutathione on the Liver Damage Induced by Carbon Tetrachloride in Rats. J. Pharm. Soc. Korea, 1987; 31(3): 133-139. 22. Cai Z., et al., A Capsule Review of Recent Studies on the Application of Mass Spectrometry in the Analysis of Chinese Medicinal Herbs. J. Mass Spectrom., 2002; 37(10): 1013-1024. 23. Cao L. Z., Lin Z. B., Regulation of Maturation and Function of Dendric Cells by Genoderma lucidum Polysaccharides. Immunol. Lett., 2002; 83(3): 163-169. 24. Cao L. Z., Lin Z. B., Comparison of the Effects of Polysaccharides from Wood-cultured and Bag-cultured Ganoderma lucidum on Murine Spleen Lymphocyte Proliferation in vitro. Yao Xue Xue Bao, 2003; 38(2): 92-97. 25. Cao L. Z., Lin Z. B., Regulatory Effect of Ganoderma lucidum Polysaccharides on Cytotoxic T-lymphocytes Induced by Dendric Cells in vitro. Acta Pharmacol. Sin., 2003; 24(4): 321-326. 26. Cao R., et al., Treatment of 232 Cases of Alopecia Areata with Ganoderma capens. J. Beijing Med. Col, 1986; 7: 217-218. 27. Chai H., et al., Constutuents from the Fruiting Body of Ganoderma lucidum (Fr.) Karst. Zhongguo Zhong Yao Za Zhi, 1997; 22(9): 552-553, 576. 28. Chang H. M., et al, Advances in Chinese Medicinal Materials Research. World Scientific, Singapore, 1984. 29. Chang H. M., But P. H., Lingzhi. Pharmacology and Applications of Chinese Materia Medica, I. World Scientific Publishing Co. Pte Ltd., Singapore, 1986; 642-653. 30. Chang R., Limitations and potential Applications of Ganoderma and related Fungal Polyglycans in Clinical Onology. The First International Conference on Mushroom Biology and Mushroom Products, Hong-Kong 1993 : 96. 31. Chang R., The Central Importance of the Beta-glucan Receptor as the Basis of Immunologic Bioactivity of Ganoderma Polysaccharides. Reishi. T. Mizuno, B. K. Kim eds., II Yang Press, Seoul, 1996; 177-179. 32. Chang R. Y., Potential Application of Ganoderma Polysaccharides in the Immune Surveillance and Chemoprevention of Cancer. Proceedings of the Second International Congress,, Mushroom Biology and Mushroom Products., D. J. Royse ed., 1996; 153-160. 33. Chang R. Y., Role of Ganoderma Supplementation in Cancer Management. The 1st International Symposium on Ganoderma lucidum in Japan, Tokyo, November 17-18, 1997, Lecture 2.

34. Chang R., Effective Dose of Ganoderma in Humans. 5th International Mycological Congress, Vancouver, B.C., August 14-21, 1994; Taipei, Taiwan: Applied Microbiology Dept., National Taiwan University, 1995; 117-121. 35. Chen A. W., Topical Use of Ganoderma Mushrooms. The Mushrrom Growers Newsletter V (11), March, 1997. 36.Chen J. H., Jiang R. L., A Pharmacognostical Study of the Chinese Drug Lingzhi (Ganoderma). Yao Xue Xue Bao, 1980; 15(4): 234-244. 37. Chen K., Zhang W., Advances in Anti-aging Herbal Medicines in China. Abstr. Chin. Med., 1987; 1: 309-330. 38. Chen K., Li C., Recent Advances in Studies on Traditional Chinese Antiaging Materia Medica. J. Tradit. Chin. Med., 1993; 13(3): 223-226. 39. Chen L. J., et al., Inhibition of Mixture of Lucid Ganoderma and Lucid Ganoderma Spore on Tumor Cell in vitro and in vivo. Ai Zheng, 2002; 21(12): 1341-1344. 40. Chen R., et al., Chemical Constituents of the Spores from Ganoderma lucidum. Zhiwu Xuebao, 1991; 33: 65-68. 41. Chen R. Y., Yu D. Q., Application of 2D NMR Techniques in the Structure Determination of Ganosporelactone A and B. Yao Xue Xue Bao, 1991; 26(6): 430-436. 42. Chen R. Y., Yu D. Q., Studies on the Triterpenoid Constituents of the Spores from Ganoderma lucidum Karst. Yao Xue Xue Bao, 1991; 26(4): 267-273. 43. Chen T. W., et al., In vitro Cytotoxicity of Ganoderma lucidum on Oral Cancer Cells. Zhonghua Yi Xue Za Zhi (Taipei), 1991; 48(1): 54-58. 44. Chen W. C., et al., Effects of Ganoderma lucidum and Krestin on Cellular Immunocompetence in Gamma-irradiated Mice. Am. J. Chin. Med., 1995; 23(1): 71-80. 45. Chen W. C., et al., Effects of Ganoderma lucidum and Krestin on Subset T-cell in Spleen of Gamma-irradiated Mice. Am. J. Chin. Med.,1995; 23(34): 289-298. 46. Chen W. W., The Effect of Lingzhi Injection and 3 Kinds of its Extracts on the Level of 2,3-Diphosphoglyceric Acid in Erythrocytes. Zhong Xi Yi Jie Za Zhi, 1983; 3(2): 106-108. 47. Chen X., et al., Treatment of 19 Cases of Dermato-myositis and Multiple Myosistis with Ganoderma capense. J. Clin. Dermatol., 1987; 16: 112. 48. Chen Z. Y., et al., Effects of Six Edible Plants on the Development of AFB1-induced Gamma-glutamyltranspeptidase-positive Hepatocyte Foci in Rats. Zhonghua Zhong Liu Za Zhi, 1987; 9(2): 109-111. 49. Cheng T. Q., et al., New techniques of Cultivating Ganoderma lucidum (W. Curt.:Fr.) Karst., Rev. with Woodlog. Zhongguo Zhong Yao Za Zhi, 1993; 18(5): 272-274, 317-318. 50. Cheng Z., et al., Effects of Ling Zhi on Hemorrheology Parameters and Symptoms of Hypertension Patients with Hyperlipidemia and Sequelae of Cerebral Thrombosis. S. Zhu, Mori M. eds., The Research on Ganoderma lucidum (part one), Shanghai Medical University Press, Shanghai, 1993.
51. Cherfas J., Disappearing Mushrooms: Another Mass Extinction? Science, 1991; 254: 1458. 52. Cheong J., et al., Charactreization of an Alkali-extracted Peptidoglycan from Korean Ganoderma lucidum. Arch. Pharm Res., 1999; 22(5): 515-519. 53.Cheung H. Y., et al, Identification and Quantification of Base and Nucleoside Markers in Extracts of Ganoderma lucidum, Ganoderma japonicum and Ganoderma Capsules by Micellar Electrokinetic Chromatography. J. Chromatogr. A., 2001; 911(1): 119-126. 54. Cheung W. M., Ganoderma Extract Activates MAP Kinases and Induces the Neuronal Differentiation of Rat Phreochromocytoma PC12 Cells. FEBS Lett., 2000; 486(3): 291-296. 55. Chiang H., Wann M., Improved Assay for Germanium in Crude Drugs. J. Taiwan Pharm. Assoc., 1986; 38: 189-198. 56. Chien C. M., et al., Cell Phenotype Analysis Using a Cell Fluid-based Microchip with High Sensitivity and Accurate Quantitation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2003; 795(1): 1-8. 57. Chihara G., Recent Progress in Immunopharmacology and Therapeutic Effects of Polysaccharides. Dev. Biol. Stand., 1992; 77: 191-197. 58. Chikashige M., Oriental Alchemy. Samuel Weiser, New York, 1974. 59. Chilto J. S., The first International Conference on Mushroom Biology and Mushroom Products. Helbalgram, 1994; 31: 57. 60. Chinese Herbal Pharmacopoeia, 2002; 93. 61. Chinese Medicine Standarization & Certification Project Team. Monograph on Linhzhi. University of Hong Kong, 2001. 62. Chiu S. W., et al., Nutritional Value of Ganoderma Extract and Assessment of its Genotoxicity and Antigenotoxicity using Comet Assays of Mouse Lymphocytes. Food Chem. Toxicol., 2000; 38(2-3): 173-178. 63. Chiu S. W., et al., Themes for Mushroom Exploitation in the 21st Century: Sustainability, Waste Management, and Conservation. J. Gen. Appl. Microbiol., 2000; 46(6): 269-282. 64. Cooke W., The Ecology of Fungi. CRC Press, Roca Raton, Fl., 1979. 65. Chu F., et al., Protection of Nucleated Bone Marrow Cells of Mice against the Effect of Radiation-induced Micronucleus Formation with Polysaccharides Extracted from Zizhi (Ganoderma). Fushe Fanghu, 1988; 8(1): 16-20; CA. 109(5): 34562u. 66. Chung K, et al., Mycelial Growth of Ganoderma lucidum and Grifola frondosa in Milk Whey. Han’guk Kyunhakhoechi, 1991; 19: 61-65. 67. Chung W. Y., et al., Assessment of Membrane Protection by Traditional Chinese Medicine using a Flow Cytometric Technique: Preliminary Findings. Redox Rep., 2003; 8(1): 31-33. 68. Corrada, M., et al., Nonsteroidal anti-inflammatory drugs and the risk of Alzheimers disease. Neurology, 1996; 46: A433. 69. Crispan E. V., Sands A., Nutritional Value. Edible Mushrooms. Academic Press, New York, 1978
70.Cuella M. J. J., Giner R. M., two Lanostane Derivatives as Phospholipase A2 Inhibitors. J. Nat. Prod., 1996; 59(10): 977-999. 71. Cui G. H., et al., Anti-hyperlipemia and Anti-oxidation Effects of Xue Zhi Ling. Zhongguo Zhong Xi Yi Jie He Za Zhi, 1993; 13(5): 261, 281-283. 72. Dai J., et al., Determination of Nucleoside in Siweilingzhi Mixture by HPCE. Zhongguo Zhong Yao Za Zhi, 2002; 27(9): 665-668. 73. Dai Y-R., et al., Effects of Extracts of Some Medicinal Plants on Superoxide Dismutase Activity in Mice. Planta Medica, 1987; 53(3): 309-310. 74. Dai Y., Yin Y., Inhibition of Type B Monoamine Oxidase by Chinese Medicinal Materials. Chin. J. Geriatrics, 1987; 6: 27-30. 75. Departament of Health, Taiwan, April 8, 2002. 76. Dharmananda S., et al., Herbal Foods in Asia: Role in the Prevention and Treatment of Cardiovascular Diseases. Nutrition and Heart Disease II. R. R. Watson ed., CRC Press, Inc., Boca Raton, Florida, 1986; 96-97. 77. Dharmananda S., Chinese Herbal Therapies for Immune Disorders. Institute for Traditional Medicine and Preventive Health Care, Portland, Oregon, 1988; 9-35. 78. Dharmananda S., Medicinal Mushrooms. Bestway Magazine, July 1988, 54-58. 79. Di X, et al., Fingerprint Profiling of Acid Hydrolyzates of Polysaccharides Extracted from the Fruiting Bodies and Spores of Lingzhi by High-performance Thin-layer Chromatography. J. Chromatogr., 2003; 1018(1): 85-95. 80. Ding G., Anit-arrhythmia Agents in Traditional Chinese Medicine. Abs. Chin. Med.,1987; 1: 287-308. 81. Ding P., et al., Effects of Places and Stages on the Contents of Ganoderic Acid B fro Ganoderma lucidum. Zhong Yao Cai, 1999; 22(6): 271-272. 82. Ding P., et al., Comparison of the Components of Ganoderma lucidum and Ganoderma japonicum. Zhong Yao Cai, 1999; 22(9): 433-435. 83. Do J-H., Kim S-D., Properties of Amylase Prodused from Higher Fungi Genoderma lucidum. Sanop Misaengmul Hakhoechi, 1985; 13: 173-178; CA. 104: 2589p. 84. Do J-H., Kim S-D., Enzymatic Properties of a Cellulase from Ganoderma lucidum. Han’guk Kyunhakhoechi, 1986; 14: 79-84; CA. 105: 16758u. 85. Dubs H., „The Beginning of Alchemy”, Isis, 1949; 2:62-86. 86. Dubs H., The History of Former Han Dynasty by Pan Ku; Volume Two. Waverly Press, Baltimore, 144: 91, 239. 87. Davis T. L., Lu-Ch’iang Wu, „Chinese Alchemy”. The Scientific Monthly, 1930; 31:225-235. 88. Davis T. L., Kuo-Fu C., The Inner Chapter of the Pao-P’u-Tzu. Proceedings of the American Academy of Arts and Sciences, 1938-42; 74 Sect. 89101:297-327. 89. Davis T. L., The Chinese beginning of Alchemy. Endevour, 1943; 2(8): 154-60 90. Ebina T, et al., Antitumor Effect of PSK (1). Interferon Inducing Activity and Intratumoral Administration. Gon to Kagaku Ryoho, 1987; 14: 18411846; CA. 107: 108960e.
91. Ebina T., Antitumor Effect of PSK. (2) Effector Mechanism of Antimetastatic Effect in the Double Grafted Tumor System. Gon to Kagaku Ryoho, 1987; 14: 1847-1853; CA. 107: 108961f. 92. Eo S. K., et al., Antiviral Activities of Various and Methanol Soluble Substances Isolated from Ganoderma lucidum. J. Ethnopharmocol., 1999; 68(13): 129-136. 93. Eo S. K., et al., Antiherpetic Activities of Various Protein Bound Polysaccharides Isolated from Ganoderma lucidum. J. Ethnopharmacol., 1999; 68(13): 175-181. 94. Eo S. K., et al., Possible Mode of Antiviral Activity of Acidic Protein Bound Polysaccharide Isolated from Ganoderma lucidum on Herpes Simplex Viruses. J. Ethnopharmacol., 2000; 72(3): 475-481. 95. Espenshade M. A., Griffith E. W., Tumor-inhibiting Basidiomycetes. Isolation and Cultivation in the Laboratory. Mycology, 1966; 58: 511-517. 96. Fang Q. H., Zhong J. J., Two-stage Culture Process for Improved Production of Ganoderic Acid by Liquid Fermantation of Higher Fungus Ganoderma lucidum. Biotechnol. Prog., 2002; 18(1): 51-54. 97. Farnworth N. R., et al., Siberian Ginseng (Eleuthrococcus senticosus): Current Status as an Adaptogen. Economic and Medical Plant Research, I. H. Wagner, H. Hikon, N. R. Farnsworth ed., Academic Press, New Press, 1985; 155-215. 98. Feifel E., Pao-P’u Tzu Nei-P’ien. Chapter XI, Monumenta Serica, 1946; 11:1-32. 99. Franz G., Structure-activity Relation of Polysaccharides Antitumor Activity. Farm. Tijdschr. Belg., 1987; 64: 301-311. 100. Fu H. D., Wang Z. Y, The Clinical Effects of Ganoderma lucidum Spore Preparations in 10 Cases of Atropic Myotonia. J. Tradit. Chin. Med., 1982; 2(1):63-65. 101. Fujimoto T., et al., Evaluation of Basic Procedures for Adoptive Immunotherapy for Gastric Cancer. Biotherapy, 1992: 5: 153-163. 102. Fulder S., The Tao of Medicine. Destiny Books, Inner Traditions Ibt’l., Rochester, Vermont, 1987; 145-146, 161-162, 169-171, 174, 212. 103. Fung P-H. et al., Glycoside Inhibitor from Ganoderma japonicum. First International Conference on Mushroom Biology and Mushroom Products. Hong Kong, August 23-26. Programme and Abstracts. The Chinese University of Hong Kong, 1993; 103: 80-83. 104. Furuya T., et al., Isolation of Ganodosterone and Ganoderic Acisd as Liver Function Stimulants. Jap. Pat. 62 270595, 1987; CA. 109(18): 156253q. 105. Fushitani S., et al., Studies on Attenuation of Post-ischemic Brain Injury by Kampo Medicines-inhibitory Effects of Free Radical Production. II. Yakugaku Zasshi, 1995; 115(8): 611-617. 106. Futrakul N., et al., Treatment with Vasodilators and Crude Extract of Ganoderma lucidum Suppresses Proteinuria in Nephrosis with Focal Segmental Glomerulosclerosis. Nephron., 2002; 92(3): 719-720.
107. Futrakul N., et al., Treatment of Glomerular Endothelial Dysfuction in Steroid-resistant Nephrosis with Ganoderma lucidum, Citams C, E and Vasodilators. Clin. Hemorheol. Microcirc., 2003; 29(3-4): 205-210. 108. Gale publ., The Gale Encyclopedia of Alternative Medicine. Gale Group Publishers, 2002; 443. 109. Gao B., Yang G., Effects of Ganoderma Applanatum Polysaccharide on Cellular and Humoral Immunity in Normal and Sarcoma 180 Transplanted Mice. Phythother. Res., 1991; 5: 134-138. 110. Gao J. J., et al., New Triterpene Aldehydes, Lucialaldehydes A-C, from Ganoderma lucidum and their Cytotoxicity against Murine and Human Tumor Cells. Chem. Pharm. Bull., 2002; 182(2): 155-161. 111. Gao L-H., Wang Z-Y., The Inefficiency of Nucleic Acid Treatment in 9 Cases of Progresive Muscular Dystrophic Disease. Beijing Medical Journal, 1981; 3(6): 347-348. 112. Gao Y., et al., Mechanism of the Antiulcerogenic Effect of Ganoderma lucidum Polysaccharides on Indomethacin-induced Lesions in the Rat. Life Sci., 2002; 72(6): 731-745. 113. Gao Y., et al., Effect of Ganopoly (a Ganoderma lucidum Polysaccharide Extract) on the Immune Functions in Advanced-stage Cancer Patients. Immunol. Invest., 2003; 32(3): 201-215. 114. Garcha H. S., et al., Nutritional Importance of Mushrooms. Mushroom Biology and Mushroom Products, S-T. Change ed., The Chinese University Press, Shatin, Hong Kong, 1993; 227-236. 115. Gau J. P., The Lack of Antiplatelet Effect of Crude Extracts from Ganoderma lucidum on HIV-positive Hemophiliacs. Am. J. Chin. Med., 1990; 18(3-4): 175-179. 116. Gengtao L., et al., Some Pharmacological Actions of the Spores of Ganoderma lucidum and the Mycelium of Ganoderma capense (Lloyd) Teng. Cultivated by Submerged Fermentation. Chin. Med. J., 1979; 92(7): 496-500. 117. Ghafar M. A., et al., Regression of Prostate Cancer following Administration of Genistein Combined Polysaccharide (GCP), a Nutritional Supplement: a Case Study. J. Altern. Complement. Med., 2002; 8(4): 493-497. 118. Giner-Larza E. M., et al., On the Anti-inflammatory and Anti-phospholipase A(2) Activity of Extracts from Lanostane-rich Species. J. Ethnopharmacol., 2000; 73(1-2): 61-69. 119. Go P., Chung C. H., Adjuvant PSK Immunotherapy in Patients with Carcinoma of the Nasopharynx. J. Int. Med. Res., 1989; 17: 141-149. 120. Go³¹b J., et al., Immunologia. Wydawnictwo Naukowe PWN, Warszawa, 2002. 121. Gong Z., Lin Z. B., The Pharmacological Study of Lingzhi (Ganoderma lucidum) and the Research of Therapeutical Principle of „Fuzheng Guben” in Traditional Chinese Medicine. Pei-Ching I Hsueh Yuan Hsueh Paoi, 1981; 13: 6-10. 122. Gray W. D., The Use of Fungi as Food and in Food Processing. CRC Press, Boca Raton, Fl., 1970; 100-173.
123. Gray W. D., The Use of Fungi as Food and in Food Processing. CRC Press, Boca Raton, Fl., 1973; 205-209. 124. Gregory F. J., et al., Studies on Antitumor Substances Produced by Basidiomycetes. Mycologia, 1966; 58:80. 125. Grüter A., et al., Antimutagenic Effects of Mushrooms. Mut. Res., 1990; 231: 243-249. 126. Gu B. K., 10 Cases of Cavernous Hemangioma Treated with Injection of „Xiao Zhi Ling” Solution. J. Tradit. Chin. Med., 1983; 3(4): 289-290. 127. Guan H. Ch., Cong Z., Effects of Ling Zhi polysaccharide D6 on the Biosynthesis of Nucleic Acid and Protein and its Preliminary Analysis. Yao Hsueh T’ung Pao, 1982; 17(3): 177-178; CA. 97: 155971u. 128. Gupta S. K., et al., Ganoderma lucidum: Partial Characterization of Spore and Whole Body Antigenic Extracts. J. Investig. Allergol. Clin. Immunol., 2000; 10(2): 83-89. 129. Ha T. B., et al., New Lanostanoids from Ganoderma lucidum that Induce NAD9P0H:quinone Oxidoreductase in Cultured Hepalcic7 Murine Hepatoma Cells. Planta Med., 2000; 66(7): 681-684. 130. Haak-Frendscho M., et al., Ling Zhi-8: a Novel T Cell Mitogen Induces Cytokine Production and Upregulation of ICAM-1 Expression. Cell. Immonol., 1993; 150(1): 101-113. 131. Halstead B. W., Hood L. L., Natural Methods to Enhance Immunity. Bulletin of the Oriental Healing Arts Institute of U.S.A, 1984; 9(8): 377. 132. Hamuro J., et al., Beta-(1,3)-glucans as a Probe for T Cell Specific Immune Adjuvants: Enhanced in vitro Generation of Cytotoxic T Lymphocytes. Cell. Immunol., 1978; 38:328. 133. Hanssen V. H-P., Schädler M., Pilze als Volksmittel in der Chinesischen Medicine. Deutsche Apoth.-Zeit., 1982; 122: 1844-1848. 134. Haranaka K., et al., Antitumor Activities and Tumor Necrosis Factor Producibility of Traditional Chinese Medicines and Crude Drugs. Cancer Immunol. Immunother., 1985; 20: 1-5 135. Harris R. S., Thimann K. V., Vitamins and Hormones: Advances in Research and Applications. VII. Academic Press Inc., New York, 1949; 39. 136. Hartwell J. L., Abbott B. J., Antineoplastic Principals in Plants. Advances in Pharmacology and Chemotherapy, 1969; 7: 117-209. 137. Hartwell J. L., Plants Used Against Cancer. J. Nat. Prod., 1971; 34(4): 419. 138. Hartwell J. L., Plants Used against Cancer. Lloydia, 1971; 34: 386-437. 139. Hasegawa Y., Ganoderma’s Current Status in the World and its Cultivation. The 1st International Symposium on Ganoderma lucidum in Japan, Tokyo, November 17-18, 1997, Lecture 14. 140. Hattori M., et al., Inhibitory Effects of Components from Ganoderma lucidum on the Growth of Human Immunodeficiency Virus (HIV) and the Protease Activity. The 1st International Symposium on Ganoderma lucidum in Japan, Tokyo, November 17-18, 1997, Lecture 8. 141. Hau D. M., Shieh J. J., Combined Rffects of ganoderma lucidum and Taxol on Experimental Liver Cancer. 94 International Symposium on Ganoderma
Research, Program and Abstracts, Paper 1-4, Beijing Medical University, Beijing, October 24-26, 1994. 142. He Y., et al., Chemical Studies on Immunogically Active Polysaccharides of Ganoderma lucidum (Leys. Ex Fr.) Karst. Zhongguo Zhong Yao Za Zhi, 1992; 17(4): 226-228, 256. 143. van der Hem L. G., et al., Prolongation of Allograft Survival with Ling Zhi-8, a New Immunosuppresive Drug. Transplant. Proc., 1994; 26(2): 746. 144. van der Hem L. G., et al., Ling Zhi-8: Studies of a New Immunomodulating Agent. Transplantation, 1995; 60(5): 438-443. 145. van der Hem L. G., et al., Ling-Zhi-8: a Fungal Protein with Immunomodulatory Effects. Transplant. Proc., 1996; 28(2): 958-959. 146. Heng Z., et al., Effects of Ling Zhi on Stress Ulcer in Mice and its Anatonism to Acetocholine. S. Zhu, M. Mori eds., The Research on Ganoderma lucidum (part one), Shanghai Medical University Press, Shanghai, 1993. 147. Hervey A. H., A Survay of 500 Basidiomycetes for Antibacterial Activity. Bull. Torrey Bot. Club, 1947: 74: 476-503. 148. Hesseltine C. W., Wang H. L., ed., Indigenous Fermented Food of NonWestern Origin. Mycologia Memoir no. 11, New York Botanical Garden & The Mycological Society of America, J. Cramer, Berlin, 1986. 149. Hijikata Y., Yamada S., Effect of Ganoderma lucidum on Postherpetic Neuralgia. Am. J. Chin. Med., 1998; 26(3-4): 375-381. 150. Hikiami H., et al., Comperative Studies of Keishi-bukuryo-gan and Pentoxifylline on RBC Deformability in Patients with „Oketsu” Syndrome. Phytomedicine, 2003; 10(6-7): 459-466. 151. Hikino H., Recent Research on Oriental Medicinal Plants. Economic and Medicinal Plant Research. I. I. H. Wagner, H. Hikono, N. R. Farnsworth ed., Academic Press, 1985; 53-85. 152. Hikino H, et al., Isolation and Hypoclycemic Activity of Ganoderans A and B, Glycans of Ganoderma lucidum Fruit Bodies. Planta Med., 1985; 51(3): 339-340. 153. Hikino H., Mizuno T., Hypoglycemic Actions of Some Heteroglycans of Ganoderma lucidum Fruit Bodies. Planta Med., 1989; 55(4): 385. 154. Hikino H., et al., Mechanisms of Hypoglycemic Activity of Genoderan B: a Glycan od Ganoderma lucidum Fruit Bodies. Planta Med., 1989; 55(5): 423-428. 155. Hirotani M., et al., A Ganoderic Acid Derivative, a Highly Oxygenated Lanostane-type Triterpenoid from Ganoderma lucidum. Phytochemistry, 1985; 24: 2055-2061. 156. Hirotani M., et al., Studies on the Metabolites of Higher Fungi. Part 6. Ganodermic Acids T, S and R, New Triterpenoids from the Cultured Mycelia of Ganoderma lucidum. Chem. Pharm. Bull., 1986; 34(5): 2282-2285. 157. Hirotoni M., Furuya T., Ganoderic Acid Derivatives, Highly Oxygenated Lanostane-type Triterpenoids, from Ganoderma lucidum. Phytochemistry, 1986; 25: 1189-1193. 158. Hirotani M., et al., Ganoderic Acid Derivatives and Ergost-4,7,22-triene-3,6-dione from Ganoderma lucidum. Phytochemistry, 1987; 26(10): 2797-2803.
159. Hiyama Y., et al., A Case Report of Moyamoya Disease: Successfully Treated with Chinese Medicine. Am. J. Chin. Med., 1992; 20(3-4): 319-324. 160. Hobbs C., Medicinal Mushrooms. An Exploration of Tradition, Healing, and Culture. Reishi, Shiitake, Maitake, Kombucha, and more. 2nd ed. Botanica Press Inc., Santa Cruz, CA, 1995. 161. Hobbs C., Calm your Spirit with the Revered Reishi Mushroom. Herbs for Health, Sep-Oct, 1999; 40-42. 162. Horner W. E., et al., Basidiomycete Allergens: Comparison of Three Ganodermataceae Species. Allergy (Copenhagen), 1993; 48: 110-116. 163. Horrobin D. F., Essential Fatty Acids: A Review. Clinical Uses of Fatty Acids, D. F. Horrobin ed., Eden Press, Inc., 1982; 3-36. 164. Hosokawa M., et al., Importance of Timing for Combination in Immunotherapy. Manipulation of Host Defense Mechanisms, T. Aoki ed., Excerpta Medica, International Congress Series 576, Amsterdam, 1981. 165. Hou C., et al., Chemical Constituents of the Spores from Ganoderma lucidum. Acta Bot. Sin., 1988; 22: 837-840. 166. Hseu R. S., Recent Advances in Molecular Systematics of the Ganoderma lucidum Complex. The 1st International Symposium on Ganoderma lucidum in Japan, Tokyo, November 17-18, 1997, Lecture 10. 167. Hsieh C., Yang F. C., Reusing Soy Residue for the Solid-state Fermentation of Ganoderma lucidum. Bioresour. Technol., 2004; 91(1): 105-109. 168. Hsieh T. C., Wu J. M., Mechanism of Action of Herbal Supplement PCSPES: Elucidation of Effects of Individual Herbs of PC-SPES on Proliferation and Prostate Specific Gene Expression in Adrogen-dependent LNCaP Cells. Int. J. Oncol., 2002; 20(3): 583-588. 169. Hsu H. Y., et al., Radioprotective Effect of Ganoderma lucidum (Letss. Ex Fr.) Karst after X-ray Irradiation in Mice. Am. J. Chin. Med., 1990; 18(12): 61-69. 170. Hsu H-Y., Oriental Materia Medica: A Concise Guide. Oriental Healing Arts Institute, Long Beach, California, 1986; 640-641. 171. Hsu M. J., et al., Polysaccharide Purified from Ganoderma lucidum Inhibits Spontaneous and Fas-mediated Apoptosis in Human Neutrophils through Activation of the Phosphadylinositol 3 Kinase/Akt Signaling Pathway. J. Leukoc. Biol., 2002; 72(1): 207-216. 172. Hsu M. J., et al., Signaling Mechanisms of Enhanced Nutrophil Phagocytosis and Chemotaxis by the Polysaccharide Purifued from Ganoderma lucidum. Br. J. Pharmacol., 2003; 139(2): 289-298. 173. Hu B., But P., Chinese Materia Medica for Radiation Protection. Abs. Chin. Med., 1987; 1: 475-490. 174. Hu H., et al., Ganoderma lucidum Extract Induces Cell Cycle Arrest and Apoptosis in MCF-7 Human Breast Cancer Cell. Int. J. Vancer, 2002; 102(3): 250-253. 175. Hu Y. H., Lin Z. B., Effects of Polysaccharides Isolated from Mycelia of Ganoderma lucidum on HL-60 Cell Apoptosis. Acta Pharm Sin., 1999; 34: 268-271.
176. Huang K. C., The Pharmacology of Chinese Herbs. CRC Press, Boca Raton, Fl., 1993. 177. Huang S., et al., Effects of Ganoderma lucidum Extracts and their Constituents on the Spontaneous Beating of Myocardial Cell Sheet in Culture. Shoyakugaku Zasshi, 1991; 45: 132-136. 178. Huidi F., Zhiyuan W., The Clinical Effects of Ganoderma lucidum Spore Preparations in 10 Cases of Atropic Myotonia. J. Trad. Chin. Med., 1982; 2(1): 63-65. 179. Human Institute of Pharmaceutical Industry, No. 201 Research Group. A Spot Survey on the Prevention of Acute Unadapted Symptoms at Plateau with Ganoderma. Chinese Traditional and Herb Drugs, 1979; 6: 29-31 180. Hung-Cheh C., Mieng-hua W., Improved Assay for Germanium in Crude Drugs. J. Taiwan Pharm. Assoc., 1986; 38: 189-198. 181. Hung W. S., et al., Cytotoxocity and Immunogenicity of Sachachitin and its Mechanism of Action on Skin Wound Healing. J. Biomed. Mater. Res., 2001; 56(1): 93-100. 182. Iizuka C., et al., Antiviral Composition Extracts from Basidiomycetes. Eurp Pat. Appl. EP 464,311, 1990. 183. Ikebe K., et al., Behaviur of Several Elements in Food. IV. Contents of 17 Metal Elements in Food Determination by Inducively Coupled Plasma Atomic Emission Spectrometry. Vegetables, Fruits, Tubers, and Mushrooms. Shokuhin Eiseigaku Zasshi, 1990; 31: 382-393. 184. Ikekawa T., at al., Antitumor Action of Some Basidiomycetes, Especially Phellinus Linteus. Jap. J. Cancer Res., 1968; 59: 155-157. 185. Ikekawa T., et al., Antitumor Activity of Aqueous Extracts of Edible Mushrooms. Cancer Res., 1969; 29: 734-735. 186. Inoue S., Honda K., Sleep-promoting Effects of a Bracket Fungus, Fomes japonicus. Sleep 86. Eighth European Congress on Sleep Research, Szeged, Hungary, Sept. 1-5, 1986. W. P. Koella et al. ed., Gustav Fischer Verlag, Stuttgart, 1988; 338-339. 187. Institute for Natural Products Research. Natural Dietary Supplements: A Desktop Reference. „Reishi”. 1998. 188. Ito H., et al., Studies on Antitumor Activity of Basidiomycete Polysaccharides. I. Antitumor Effect of Wild and Cultured Basidiomycetes on Sarcoma 180 Subcutaneously Implanted in Mice. Mie Med. J., 1972-1973; 22: 103-113. 189. Ito H., et al., Studies on Antitumor Activity of Basidiomycete Polysaccharides. IV. Antitumor Effect of Fungal and Bacterial Polysaccharides on Mouse Tumors. Mie Med. J., 1973; 23: 117-127. 190. Ito H., et al., Studies on Antitumor Activity of Basidiomycetes Polysaccharides. VII. Antitumor Effect of the Polysaccharides Preparations from Ganoderma lucidum on Mouse Sarcoma 180. Mie Medical Journal, 1977; 26(2-3): 147-152. 191. Ito M., et al., Anti-alergic Effects of Reishi (Ganoderma lucidum). Poster 24. International Congress on Natural Products Research. American Society of Pharmacognosy and Japanese Society of Pharmocognosy, Park City, Utah, July
17-21, 1988. University of Utah, Dept. of Medicinal Chemistry, Salt Lake City, Utah, 1988. 192. Iwatsuku K., et al., Lucidenic Acids P and Q, Methyl Lucidenate P, and other Triterpenoids from the Fungus Ganoderma lucidum and their Inhibitory Effects on Epstein-Barr Virus Activation. J. Nat. Prod., 2003; 66(12): 1582-1585. 193. Jain A. C., Gupta S. K., The Isolation of Landosta-7,9(11),24-trien-3b,21diol from the Fungus Ganoderma australe. Phytochemistry, 1984; 23: 686-687. 194. Jakucs E., et al., Some Characteristics and Partial Purification of the Ganoderma lucidum Cellulase System. Acta Microbiol. Immunol. Hung., 1994; 41(1): 23-31. 195. Jeong H., et al., Studies on the Anticomplementary Activity of Korean Higher Fungi. Korean J. Mycol., 1990; 18: 145-148. 196. Jia Y., et al., Effects of Ling Zhi on the Production of Inetrleukin-1 (IL1). Influence of Ling Zhi on Natural Killer Cell – Immunopharmacological Study (5). The Research on Ganoderma lucidum (part one), S. Zhu, Mori M., ed., Shanghai Medical University Press, Shanghai, 1993; 254-258. 197. Jia Y., et al., Effects of Ling Zhi on Hemopoietic System in Mice. Immunopharmacological Study (11). The Research on Ganoderma lucidum (part one), S. Zhu, Mori M., eds., Shanghai Medical University Press, Shanghai, 1993; 284-288. 198. Jiang M., et al., Analgesic, Sedative Effects and Promoting Tolerance Activity of Ling Zhi in Mouse. S. Zhu, M. Mori eds., The Research on Ganoderma lucidum (part one), Shanghai Medical University Press, Shanghai, 1993. 199. Jiang Y., et al., Effects of Ling Zhi on Superoxide Anion Radicals. S. Zhu, M. Mori eds., The Research on Ganoderma lucidum (part one), Shanghai Medical University Press, Shanghai, 1993. 200. Jifeng W., et al., Study of the Action of Ganoderma lucidum on Scavenging Hydroxyl Radical from Plasma. J. Tradit. Chin. Med., 1985; 5(1): 55-60. 201. Jin H., et al., Treatment of Hypertension by Lingzhi Combined with Hypotensor and its Effects on Arterial, Arteriolar and Capillary Pressure Microcirculation: Strategy for the Scientific Evaluation. H. Niimi, et al., eds., Excerpta Medica, International Congress Series, 1996; 1117: 131-138. 202. Jingrong W., The Pinyin Chinese-English Dictionary. The Commercial Press, Beijing, 1979. 203. Jones K., Reishi Mushroom: Longevity Herb of the Orient. Health World, Nov-Dec., 1990; 28-31. 204. Jones K., Reishi (Ganoderma) Longevity Herb of the Orient, Part 1. Towsend Letter for Doctors, October, 1992; 814-818 205. Jones K., Reishi (Ganoderma) Longevity Herb of the Orient, Part 2. Towsend Letter for Doctors, 1992 November; 1004-1012. 206. Jones K., Reishi: Ancient Herb for Modern Times. 2nd Edition, Sylvan Press. Inc., Seattle, WA., 1996. 207. Jones K., Reishi Mushroom: Ancient Medicine in Modern Times. Altern. Complem. Ther, august, 1998; 256-266.
208. Jong S. C., et al., Immunomodulatory Substances of Fungal Origin. J. Immunol. Immunopharmacol., 1991; Vol. XI(3): 115-122. 209. Jong S. C. Birmingham J. M., Medicinal Benefits of the Mushroom Ganoderma. Adv. Appl. Microbiol., 1992; 37: 101-134. 210. Junhua C., Ronglan J., A Pharmacognostical Study of the Chinese Drug Lingzhi (Ganoderma). Acta Pharm. Sin., 1980; 15: 244. 211. Juntien Z., Recent Achievements of the Institute of Materis Medica on Studies of Natural Products. Proc. of the U.S. China Pharmacology Symposium, J. J. Burns, P. J. Tsuchitani ed., Washington, D. C., 1980; 15-54. 212. Kabir Y., et al., Dietary Effect of Ganoderma lucidum Mushroom on Blood Pressure and Lipid Levels in Spontaneously Hypertensive Rats (SHR). J. Nutr. Sci. Vitaminol., 1988; 34(4): 433-438. 213. Kabir Y., Kimura S., Dietary Mushrooms Reduce Blood Pressure in Spontaneously Hypertensive Rats (SHR). J. Nutr. Sci. Vitaminol., 1989; 35: 91-94. 214. Kac D, et al., The Major Sterols from Three Species of Polyporacae. Phytochemistry, 1984; 23(11): 2686-2687. 215. Kamasuka T., et al., Antitumor Activity of Polysaccharide Fractions Prepared from some Strains of Basidiomycetes. Gann., 1968; 59: 443-445. 216. Kan Ch. Y, et al., Studies on the Antineoplastic Components of Korean Basidiomycetes. Mycellial Culture and an Antineoplastic Component of Ganoderma lucidum. Hanguk Saenghwa Hakhoe Chi, 1981; 14(2): 101-112. 217. Kandefer-Szerszen M., et al., Fungal Nucleic Acids as Interferon Inducers. Acta Microbiologica Polonica, 1979; 28(4): 277-291. 218. Kanmatsuse K, et al., Studies on Genoderma lucidum. I. Efficay against Hypertension and Side Effects. Yakugako Zasshi, 1985; 105(10): 942-947. 219. Kasahara Y., Hikino H., Central Actions of Ganoderma lucidum. Phytotherapy Res., 1987; 1(1): 17-21. 220. Kasahara Y, Hikino H., Central Actions of Adenosine, a Nucleotide of Ganoderma lucidum. Phytotherapy Res., 1987; 1(4): 173-176. 221. Kawagishi H., et al., 5’-Deoxy-5’-methylsulphinyladenosine, a Platelet Aggregation Inhibitor from Ganoderma lucidum. Phytochemistry, 1993; 32: 239-241. 222. Kawagishi H., et al., A Lectin from Mycelia of the Fungus Ganoderma lucidum. Phytochemistry, 1997; 44(1): 7-10. 223. Keruha Chemical Industry Co., Ltd., Anticarcinogen. Jap. Pat. 76 17,166, 1976; CA. 85: 190736v. 224. Kijima J., et al., Establishing a D-Galactoseamine Induced Hepatic Injury Model using Primary Cultured Rat Hepatocytes. Zoological Science (Tokyo), 1987; 4(6): 1000. 225. Kikuchi T., et al., Ganoderic Acid D, E, F, and H and Lucidenic Acid D, E, and F, New Triterpinoids from Ganoderma lucidum. Chem. Pharm. Bull., 1985; 33:2624-2427. 226. Kikuchi T, et al., Ganoderic Acid G and I and Ganolucidic Acid A and B, New Triterpenoids frmo Ganoderma lucidum. Chem. Pharm. Bull., 1985; 33: 2628-2631.
227. Kim B. K., et al., Anti-neoplastic Components of Korean Basidiomycetes. Korean J. Mycol., 1980; 8(2); BIOSIS Previews. 228. Kim B. K., et al., Studies on the Antineoplastic Components of Korean Basidiomycetes. Hanguk Kyunhakhoe Chi, 1980; 8(2): 107-113. 229. Kim B. K., et al., Anti-HIV Activities of Genoderma lucidum. Fifth International Mycological Congress Abstracts, Vancouver, BC, August 14-21, 1994. 230. Kim B. K., et al., Medicinal Efficacies of Ganoderma lucidum (XV.) Anti-HIV Activities of Ganoderma lucidum. Proceedings of the Second International Congress., Mushroom Biology and Mushroom Products., D. J. Royse ed., 1996; 187-194. 231. Kim B. K., Effects of Ganoderma lucidum on Human Leukocytes. The 1st International Symposium on Ganoderma lucidum in Japan, Tokyo, November 17-18, 1997, Lecture 1. 232. Kim C., et al., Studies on Constituents of Higher Fungi of Korea (LXIV). Constituents od Cultured and Fused Mycelia of Ganoderma lucidum. Soul Taehakkyo Yakhak Nonmunjip, 1990; 15: 38-71. 233. Kim D. H., et al., Anti-Helicobacter pylori Activity of Mushrooms. Arch. Pharm. Res., 1996; 19: 447-449. 234. Kim D. H., et al., Beta-glucuronidase-inhibitory Activity and Hepatoprotective Effect of Ganoderma lucidum. Biol. Pharm. Bull., 1999; 22(2): 162-164. 235. Kim H. S., et al., In vitro Chemopreventive Effects of Plant Polysaccharides (Aloe barbadensis miller, Lentinus edodes, Ganoderma lucidum and Coriolus vesicolor). Carcinogenesis, 1999; 20(8): 1637-1640. 236. Kim J. H., Nam J. S., Studies on Distribution of the Mononucleosides in Ganoderma lucidum. Han’guk Lyunhakhoechi, 1984; 12(3): 111-116; CA. 101: 226480x. 237. Kim K. C., Kim I. G., Ganoderma lucidum Extract Protects DNA from Strand Breakage Caused by Hydroxyl Radical and UV Irradiation. Int. J. Mol. Med., 1999; 4(3): 273-277. 238. Kim M. J., et al., Studies on Safety of Ganoderma lucidum. Korean J. Mycol., 1986; 14(1): 49-60. 239. Kim R. S., et al., Suppressive Effects of Ganoderma lucidum on Proliferation of Peripheral Blood Mononuclear Cells. Mol. Cells, 1997; 7(1): 52-57. 240. Kim S. W., et al., Mycelial Growth and Exo-polymer Production by Submerged Culture of Various Edible Mushrooms under Different Media. Lett. Appl. Microbiol., 2002; 34(1): 56-61. 241. Kim Y. S., et al., Antiherpetic Activities of Acidic Protein Bound Polysaccharide Isolated from Ganoderma lucidum Alone and in Combinations with Interferons. J. Ethnopharmacol., 2000; 72(3): 451-458. 242. Kimura Y, et al., Effects of the Extracts of Ganoderma lucidum on Blood Glucose Level in Rats. Planta Med., 1988; 54(4): 290-294. 243. Kimura Y., et al., Antitumor and Antimetastatic Effects on Liver of Triterpenoid Fractions of Ganoderma lucidum: Mechanism of Action and Isolation of an Active Substance. Anticancer Res., 2002; 22(6A): 3309-3318.
244. Kino K., et al., Isolation and Characterization of a New Immunomodulatory Protein, Ling Zhi-8 (LZ-8), from Ganoderma lucidum. J. Biol. Chem., 1989; 264(1): 472-478. 245. Kino K., et al., An Immunomodulating Protein, Ling Zhi-8 (LZ-8) Prevents Insulitis in Non-obese Diabetic Mice. Diabetologia, 1990; 33(12): 713-718. 246. Kino K., et al., Immunomodulator, LZ-8, Prevents Antibody Production in Mice. Int. J. Immunopharmacol., 1991; 13(8): 1109-1115. 247. Ko E. M., et al., Purification and Characterization of Laccase Isozymes from the White-rot Basidiomycete Ganoderma lucidum. Appl. Microbiol. Biotechnol., 2001; 57(1-2): 98-102. 248. Kohda H, et al., The Biologically Active Constituents of Ganoderma lucidum (Fr.) Karst. Histamine Release-inhibitory Triterpines. Chem. Pharm. Bull., 1985; 33(4): 1367-1374. 249. Kohlmünzer S., Farmakognozja. Wyd. V, Wydawnictwo Lekarskie PZWL, Warszawa, 2000. 250. Komoda Y., Nuclear Magnetic Resonanse Specrta of Terpenoid Constituents and their Derivatives of Ganoderma lucidum. Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku, 1985; 19: 45-54. 251. Komoda Y., et al., Ganoderic Acid and its Derivatives as Cholesterol Synthesis Inhibitors. Chem. Pharm . Bull., 1989; 37(2): 531-533. 252. Kosuge T., et al., Studies on Antitumor Activities and Antitumor Principle of Chinese Herbs. I. Antitumor Activities of Chinese Herbs. Yakugaku Zasshi, 1985; 105: 791-795. 253. Koyama K., et al., Antinociceptive Components of Ganoderma lucidum. Planta Med., 1997; 63(3): 224-227. 254. Krebs G., Research on the Sporophore Formation, the Lake as well as Phenol Oxidase and peroxidase in Ganoderma lucidum (Leyss.) Karst. Arch. Mikrobiol., 1961; 40: 94-118. 255. Kubo M., et. al., Studies on Ganoderma lucidum. IV. Effects on the Dissemenated Intravascular Coagulation. Yakugaku Zasshi, 1983; 103(8): 871-877. 256. Kumari H., Sirsi M., Purification and Properties of Endopolygalacturonase from Ganoderma lucidum. J. Gen. Microbiol., 1971; 65: 285-290. 257. Kupin V., A New Biological Response Modifier – Ganoderma lucidum – and its Application in Oncology. The 4th International Symposium on Genoderma lucidum, Program and Abstracts, Hyatt Regency Hotel, Seoul, Korea, June 10, 1992; 36-39. 258. Kureha Chemical Industry Co. Ltd., Anticarcinogen. Jap. Pat. 76 17,166, 1976; CA. 85:190736v. 259. Kurtzman R. H., Jr., Analysis, Digestibility and the Nutrinional Value of Mushrooms. Mushroom Biology and Mushroom Products, S-T. Chang ed., The Chinese University Press, 1993. 260. Lai F. G., A New Method for the Identification of the Chinese Drug Wu-Ling-Zhi and its Adulterans. Zhong Yao Tong Bao, 1985; 10(7): 15-16.
261. Lai N. S., et al., Prevetion of Autoantibody Formation and Prolonged Survival in New Zealand Black/New Zealand White F1 Mice with an Ancient Chinese Herb, Ganoderma tsugae. Lupus, 2001; 10(7): 461-465. 262. Lake R., The Remarkable Reishi. Alive, 1991. 263. Lakshimi B., et al., Antiperoxidative, Anti-inflammatory, and Antimutagenic Activities of Ethanol Extract of the Mycelium of Ganoderma lucidum Occuring in South India. Teratog. Carcinog. Mutagen., 2003; Suppl. 1: 85-97. 264. Lan J., et al., Resources and Utilization of Anticarcinogenic Medical Fungi. Zhong Yao Cai, 1999; 22(12): 614-618. 265. Landry R. J., Hypertension: Of Thickened Blood and Failing Hearts. American Health, 1984; 15. 266. Larionov L. F., Cancer Chemotherapy. Pergamon Press, New York, The Treatment of Cancer with Herbs, Biworld Pub., 1965. 267. Latta J., Miracle Mushroom Cures.Examiner, 1996; 13. 268. Lee J. W., et al., Screening of Hepatoprotective Substances from Higher Fungi by Primary Cultured Rat Hepatocytes Intoxicated with Carbon Tetrachloride. Korean J. Mycol., 1992; 20: 347-353. 269. Lee J. M., et al., Inhibition of Lipid Peroxidation and Oxidative DNA Damage by Ganoderma lucidum. Phytother. Res., 2001; 15(3): 245-249. 270. Lee M. S., Chung K-S., The Effects of Ganoderma lucidum Extracts and Filtrate of Escherichia Coli Culture on Leucocyte Chemotaxis. Korean J. Mycol., 1987; 15(1): 1-8. 271. Lee S., et al., Natural Inhibitors for Protein Prenyltransferase. Planta Med., 1998; 64(4): 303-308. 272. Lee S. S., et al., In vivo Anti-tumor Effects of Crude Extracts from the Mycelium of Ganoderma lucidum. J. Chin. Oncol. Soc., 1984; 5(3): 22-28. 273. Lee S. S., Lin Z. B., Antitumor Effects of Ganoderma lucidum. J. Chin. Med., 1995; 6: 1-12.. 274. Lee S. Y., Rhee H. M., Cardiovascular Effects of Mycelium Extract of Ganoderma lucidum: Inhibition of Sympathetic Outflow as a Mechanism of its Hypotensive Action. Chem. Pharm. Bull., 1990; 38(5): 1359-1364. 275. Lee S. Y., et al., Antiherpetic Activities of Various Protein Bound Polysaccharides Isolated from Ganoderma lucidum. J. Ethnopharmacol., 1999; 68(1-3): 175-181. 276. Lei L, Lin Z., Effects of Ganoderma Polysaccharides on the Activity of DNA Polymerase a in Spleen Cells Stimulated by Alloantigens in Mice in vitro. Beijing Yike Daxue Xuebao, 1966; 23: 329-333. 277. Lei L. S., et al., Antagonistic Effect of Ganoderma lucidum Polysaccharides on the Immunosuppresive Response Induced by Cyclosporin A, Hydrocortisone and Antitumor Agents. Chin. J. Pharmacol. Toxicol., 1993; 7(3): 183-185. 278. Li D., et al., Effects of Ling Zhi on Membranes Fluidity and Ghosts Reseal Ability of Rat Erythrocyte. S. Zhu, M. Mori eds., The Research on Ganoderma lucidum (part one), Shanghai Medical University Press, Shanghai, 1993.
279. Li D., et al., Effects of Ling Zhi on Superoxide Dismutase Activity and Protein Components of Rat Erythrocyte Membranes. S. Zhu, M. Mori eds., The Research on Ganoderma lucidum (part one), Shanghai Medical University Press, Shanghai, 1993. 280. Li G., Li B., The Study on the Fermantation Medium of Genoderma lucidum. Zhong Yao Cai, 1998; 21(8): 379-381. 281. Li H., et al., Effects of Ling Zhi on Sex Vitality and Longevity in Drosphila melanogaster. S. Zhu, M. Mori, eds., The Research on Ganoderma lucidum (Part One), Shanghai University Press, Shanghai, 1993; 289-294. 282. Li Khva Ren, et al., Anti-atherosclerotic Properties of Higher Mushrooms (a Clinico-experimental Investigation). Vopr. Pita., 1989; (1): 16-19. 283. Li M., Review of the Studies of Antineoplastic Fungal Polysaccharides. Jiangxi Zhongyiyao, 1985; 59-63. 284. Li M., et al., Diagnosis and Treatment of Spiral Dural Arteriovenous Fistulas: 110 Cases Report. Zhonghua Wai Ke Za Zhi, 2003; 41(2): 99-102. 285. Li M. C., et al., Effect of Ganoderma Polysaccharide on Intracellular Free Calcium in Murine Peritoneal Macrophage. Chin. Pharm. J., 1999; 34: 805-807. 286. Li M. C., et al., Effect of Ganoderma lucidum Polysaccharides on cAMP in Murine Peritoneal Macrophages. Zhongguo Zhong Yao Za Zhi, 2000; 25(1): 41-43. 287. Li M. C., et al., Effect of Ganoderma Polysaccharide on Intracellular Free Calcium and Intracellular pH in Murine T Cells. Chin. Pharmacol. Bull., 2001; 17: 167-170. 288. Li P., Zhang K., Isolation, Purification and Bioactivities of Exopoly Saccharides from Fermented Broth of Ganoderma lucidum.Wei Sheng Wu Xue Bao, 2000; 40(2): 217-220. 289. Li S. C., Pen T-sao Kang Mu. Shang Wu Printer, Shanghai, 1933. 290. Li T., et al., Chemical Studies on Peptidepolysaccharides of Ganoderma lucidum (W. Curt. Fr.) Karst. Zhongguo Zhong Yao Za Zhi, 1997; 22(8): 487489, 512. 291. Li W-Y, Lien E. J., Fu yhen Herbs in the Treatment of Cancer. Oriental Healing Arts International Bulletin, 1986; 11(1): 1-8. 292. Lieu C. W., et al., The Effect of Ganoderma lucidum on Induction of Differentiation in Leukemic U937 Cells. Anticancer Res., 1992; 12(4): 1211-1215. 293. Lim U, K., Choi K. S., The Study of Chemical Component on Genoderma lucidum. Seoul National University J. Agr. Sci., 1991; 16: 109-114. 294. Lin C. N., et al., Novel Cytotoxic Principles of Formosan Ganoderma lucidum. J. Nat. Prod., 1991; 54(4): 998-1002. 295. Lin J. M., et al., Evaluation of the Anti-infammatory and Liver-protective Effects of Anoectochilus formosanus, Ganoderma lucidum and Gymnostemma pentaphyllum in Rats. Amer. J. Chin. Med., 1993; 21: 59-69. 296. Lin J. M., et al., Radical Scavenger and Antihepatotoxic Activity of Ganoderma formosanum, Ganoderma lucidum and ganoderma neo-japonicum. J. Ethnopharmacol., 1995; 47(1): 33-41.
297. Lin L. J., Shiao M. S., Separation of Oxygenated Trirepinoids from Ganoderma lucidum by High-Performance Liquid Chromatography. J. Chromatogr., 1987; 410(1): 195-200. 298. Lin L. J., et al., Triterpines from Ganoderma lucidum. Phytochemistry, 1988; 27(7): 2269-2271. 299. Lin L. J., et al., Seven New Triterpines from Ganoderma lucidum. J. Nat. Prod., 1988; 51(5): 918-924. 300. Lin S. B., et al., Triterpine-enriched Extracts from Ganoderma lucidum Inhibit Growth of Hepatoma Cells via Suppressing Protein Kinase C, Activating Mitogen-activated Protein Kinases G2-phase Cell Cycle Arrest. Life Sci., 2003; 72(21): 2381-2390. 301. Lin Z. B, The Present Status of Pharmacological Studies of Ling zhi (Ganoderma lucidum) in China. Yao Hseuh Pao, 1979; 14(3):183-192. 302. Lin Z. B., Pharmacological Effects and Clinical Applications of Ganoderma lucidum. J. H. Zhou, G. Z. Liu, eds., Recent Advances in Chinese Herbal Drugs – Actions and Uses. Scientific Publishing House, Beijing, 1991; 133-140. 303. Lin Z. B., The Integrated Studies on Ganoderma lucidum Karst. Guided by Traditional Chinese Medical Theories. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2001; 21(12): 883-884. 304. Lin Z. B., Pharmacological Effects of Ganoderma lucidum. Z. B. Lin ed., Modern Research of Ganoderma lucidum. 2nd Edition, Beijing Medical University Press, Beijing, 2001; 219-283. 305. Lin Z. B., Clinical Applications of Ganoderma lucidum. Z. B. Lin ed., Modern Research of Ganoderma lucidum. 2nd Edition, Beijing Medical University Press, Beijing, 2001; 302-304. 306. Lindequist U., et al., New Active Substances from Basidiomycetes. Zeitschrift für Phyto-Therapy, 1990; 11:139-149. 307. Liu B., Bau Y. S., Fungi Pharmacopoeia (Sinica). The Kinoko Co., Oakland, California, 1980; 168-172 308. Liu G. T., et al., Some Pharmacological Effects of Alcoholic Extracts of Ganoderma lucidum and G. japonicum (Lloyd) on Mouse Liver. Yao Hsueh Hsueh Pao, 1979; 14(5): 284-287; CA. 92: 51937t. 309. Liu G-T., et al., Comparison of the Protective Actions of Dimethylbiphenyldicarboxylate, Trans-stilbene, Alcoholic Extract of Polyporous japonicus and Ganoderma towards Experimental Liver Injury in Mice. Yao Hsueh Hsueh Pao; 1979; 14(10): 598-604; CA. 93: 542y. 310. Liu G-T., et al., Effect of Ganodermas on Elevated Serum Aldolase Levels in Experimental Muscular Dystrophy Induced by 2,4-dichloro-phenoxyacetic Acid (2,4-D) in Mice. Yao Hsueh Hsueh Pao, 1980; 15(3): 142-146; CA. 93: 179561d. 311. Liu G-T., Pharmacology and Clinical Uses of Ganoderma. Mushroom Biology and Mushroom Products, S-t. Chang et al. ed., The Chinese University Press, 1993; 267-273. 312. Liu W. K., et al., Immunomodulatory Activies of Mushroom Mycelial Extracts. Mushroom Biology and Mushroom Products, S-t. Chang, et al., ed., The Chinese University Press, 1993; 285-290.
313. Liu X., et al., Antitumor Activity of the Sporoderm-broken Germinating Spores of Ganoderma lucidum. Cancer Lett., 2002; 182(2): 155-161. 314. Liu Y. H., et al., Effectiveness of Dp2 Nasal Therapy for Dp2-induced Aiway Inflammation in Mice: Using Oral Ganoderma lucidum as an Immunomodulator. 2003; 36(4): 236-242. 315. Locke S. E., Hornig-Rohan M., Mind and Immunity: Behavioral Immunology: An Annotated Bibliography 1976-1982. Institute for the Advancement of Health, New York, 1983. 316. Lou F. et al., Natural Antineoplastic Compounds and their Structureactivity Relationships. Abstracts of Chinese Medicines, 1988; 2: 484-495. 317. Lu H., et al., Prevention of the Development of Preneoplastic Lesions, Aberrant Crypt Foci, by a Water-soluble Extract from Cultured Medium of Ganoderma lucidum (Rei-shi) Mycelia in Male F344 Rats. Oncol. Rep., 2001; 8(6): 1341-1345. 318. Lu H., et al., Prevention of Development of N,N’-dimethylhydrazineinduced Colon Tumors by a Water-soluble Extract from Cultired Medium of Genoderma lucidum (Rei-shi) Mycelia in Male ICR Mice. Int. J. Mol. Med., 2002; 9(2): 113-117. 319. Lu H., et al., A Water-soluble Extract from Cultured Medium of Ganoderma lucidum (Rei-shi) Mycelia Suppresses Azoxymethane-induction of Colon Cancers in Male F344 Rats. Oncol. Rep., 2003; 10(2): 375-379. 320. Lu L., et al., Study on Certified reference Material of Germanium in Ganoderma lucidum. Wei Sheng Yan Jiu, 1998; 27(4): 283-284. 321. Lu Y., Wu L. Q., Efficacy of Intra-tumor Injection of Xiao-Zhi-Ling on Transplanted Hepatoma in Rats. World J. Gastroenterol., 2003; 9(9): 2121-2124. 322. Lu Z. W., Lin Z. B., Antagonistic Effect of Ganoderma Polysaccharides Peptide against Immunosuppression of Morphine. 94 International Symposium on Ganoderma Research, Program and Abstracts, Beijing Medical University, Beijing, October 24-26, 1994; 82. 323. Lu Z. W., Lin Z. B., Antagonistic Effects of Ganoderma Polysaccharides Peptide on Inhibition of Immune Response Caused by Repetitive in vivo Treatments of Morphine. 94 International Symposium on Ganoderma Research, Program and Abstracts, Beijing Medical University, Beijing, October 24-26, 1994; 82. 324. Lucas E. H., The Role of Folklore in Discovery and Rediscovery of Plant Drugs. Centenial Review, 1959; 3: 173-188. 325. Lui X., Hepatopathy and Uterofunctional Bleeding Mainly Treated with Ganoderma lucidum. 94 International Symposium on Ganoderma Research, Program and Abstracts, Beijing, Beijing Medical University, 1994. 326. Luo J., Lin Z. B., A New Triterpine from the Fruiting Body of Ganoderma lucidum. Yao Xue Xue Bao, 2001; 36(8): 595-598, 327. Luo J., Lin Z. B., Advances of Pharamacological Effects of Triterpines from Ganoderma lucidum. Yao Xue Xue Bao, 2002; 37(7): 574-578. 328. Luo J., et al., A New Landostane-type Triterpene from the Fruiting Bodies of Ganoderma lucidum. J. Asian Nat. Prod. Res., 2002; 4(2): 129-134.
329. Ma J., et al., New Lanostanoids from the Mushroom Ganoderma lucidum. J. Nat. prod., 2002; 65(1): 72-75. 330. Maeda Y. Y., et al., Unique Increase of Serum Protein Components and Action of Antitumor Polysaccharides. Nature, 1974; 252: 250. 331. Mahdissan S., Indian Alchemy or Rasayana in the light of Ascetism Geriatrics. Vicas Pub. House, PVT Ltd., New Delhi, 1979; 106:46, 64-65. 332. Mark W. K., Formidable Fungi: The Role of Medicinal Mushrooms. Whole Foods, October, 1998; 45-46. 333. Maruyama H., et al., Antitumor Activity of Sarcodon aspratus (Berk.) S. Ito and Genoderma lucidum (Fr.) Karst. J. Pharmacobiodyn., 1989, 12(2): 118-123. 334. Matsuki M., et al., Extraction of Antiteratogenic Glycoproteins from Basidiomycetes. Kokai Tokkyo Koho, Jap. Pat. 02 49,732; CA. 113: 120776f. 335. Matsumoto K. II, The Mysterious Reishi Mushroom. Woodbridge Press Publishing Company, Santa Barbara, California, 1979. 336. Matsunaga K., et al., Restoration of Immune Responsiveness by a Biological Response Modifier, PSK, in Aged Mice Bearing Syngeneic Transplantable Tumor. J. Clin. Lab. Immunol., 1987; 24: 143-149. 337. Mau J. L., et al., Antioxidant Properties of Several Medicinal Mushrooms. J. Agric. Food Chem., 2002; 50(21): 6072-6077. 338. Mayzumi F., et al., Cultivation of Reishi (Ganoderma lucidum). Food Reviews International, 1997; 13: 365-382. 339. McGlasson L., Reishi: Ancient Medicine is Modern Hope. Health Foods Business, January, 1992; 47-48. 340. McKenna D. J., ed., Natural Dietary Supplements: A Desktop Refeernce. Inst. Nat. Prod. Res., 1998. 341. el-Mekkawy S., et al., Anti-HIV-1 and Anti-HIV-1-protease Substances from Ganoderma lucidum. Phytochemistry, 1998; 49(6): 1651-1657. 342. Miao Y., et al., Effects of Ling Zhi on Isolated Guinea-Pig Trachea. S. Zhu, M. Mori eds., The Research on Ganoderma lucidum (part one), Shanghai Medical University Press, Shanghai, 1993. 343. Miller N., Returning to Your Roots: Traditional Chinese Medicine and the Athlete. Inside Kung Fu, January, 1995; 86-89. 344. Min B. S., et al., Triterpines from the Spores of Ganoderma lucidum and their Inhibitory Activity against HIV-1 Protease. Chem. Pharm Bull., 1998; 46(10): 1607-1612. 345. Min B. S., et al., Triterpenes from the Spores of Ganoderma lucidum and their Cytotoxicity against Meth-A and LLC Tumor Cells. Chem. Pharm. Bull., 2000; 48(7): 1026-1033. 346. Min B. S., et al., Anticomplement Activity of Terpenoids from the Spores of Genoderma lucidum. Planta Med., 2001; 67(9): 811-814. 347. Miura T., et al., Isoflavone Aglycon Produced by Culture of Soybean with Basidiomycetes and its Anti-angiogenic Activity. Biosci. Biotechnol. Biochem., 2002; 66(12): 6226-6231.
348. Miyasaka N., et al., An Immunomodulatory Protein, Ling Zhi-8, Facilitates Cellular Interaction through Modulation on Adhesion Molecules. Biochem. Biophys. Res. Commun., 1992; 186(1): 385-390. 349. Miyahara R., et al., Chemical Structures and Changes of Extracts during Growth of Reishi (ganoderma lucidum). Jap. Wood Res. Soc. J., 1987; 33(5): 416-423. 350. Miyazaki T., Nishijima M., Studies on Fungal Polysaccharides. XXVII. Structural Examination of a Water-Soluble, Antitumor Polysaccharide of Ganoderma lucidum. Chem. Pharm. Bull., 1981; 29(12): 3611-3616. 351. Miyazaki T., Nishijima M., Structural examination of an alkali-extracted, Water-soluble Heteroglycan of the Fungus Ganoderma lucidu. Carbohydrate Res., 1982; 109: 290-294. 352. Miyazaki T., Relationship Between the Chemical Structure and Antitumor Activity of Basidiomycetes Glucans. Shinkin to Shinkinsho, 1983; 24(2): 95-101; CA. 100: 79551v. 353. Mizuno D., A Possible Parameter to Classify Immunomodulators. Manipulation of Host Defence Mechanisms, T. Aoki, et al., ed., Excerpta Medica (International Congress Series 576), Amsterdam, 1981. 354. Mizuno T., et al., Studies on the Host-Mediated Antitumor Polysaccharides. II. Screening test on Antitumor Activity of Various Kinds of Polysaccharides. Shizuoka Daigaku Nogakubo Kenkyu Hokuku, 1980; 30: 41-50; CA. 94: 202749c. 355. Mizuno T., et al., Studies on the Host-Mediated Antitumor Polysaccharides. VI. Isolation and Characterization of Antitumor Active Beta-D-Glucan from Mycelial Cells of Ganoderma applanatum. Shizuoka Daigaku Nogakubu Kenkyu Hokoku, 1982; 32:41-58; CA. 98: 212585t. 356. Mizuno T., et al., Fractionation, Structural features and Antitumor Activity of Water-soluble Polysaccharide from Reishi, the Fruit Body of Ganoderma lucidum. Nippon Nogei Kagaku Kaishi, 1984, 58(9): 871-880; CA. 101: 226886j. 357. Mizuno T, Sakamura S., Medicinal and Dietary Effects of Man-nentake (Reishi). Antitumor Polysaccharides and Bitter Terpenoids. Kagaku to Seibuts, 1985; 23: 797-802. 358. Mizuno T., et al., Fractionation, Chemical Modification and Antitumor Activity of Water-insoluble Polysaccharides of the Fruiting Body of Ganoderma lucidum. Nippon Nogei Kagaku Kaishi, 1985; 59(11): 1143-1151; CA. 104: 135927u. 359. Mizuno T, et al., Antitumor Polysaccharides. XII. Immunostimulative Antitumor Effects of beta-D-glucans and Chitin Substances Isolated from Some Medicinal Mushrooms. Shizuoka Daigaku Nogakubu Kenkyu Hokoku, 1988; 2935; CA. 111: 33186d. 360. Mizuno T, et al., Mineral Composition and Germanium Content of Several Medicinal Mushrooms. Bull. Of the Faculty of Agriculture, Shizuoka University, 1988; 38: 37-46.
361. Mizuno T., Development and Utilization of Bioactive Substances from Medicinal and Edible Mushroom Fungi. II. Ganoderma lucidum. Chem. Times, 1989; (3): 50-60. 362. Mizuno T., Studies on Bioactive Substances and Medical Effects of Reishi (Ganoderma lucidum). The 1st International Symposium on Ganoderma lucidum in Japan, Tokyo, November 17-18, 1997, Lecture 7. 363. Mizushina Y., et al., An Ergosterol Peroxide, a Natural Product that Selectively Enhances the Inhibitory Effect of Linoleic Acid on DNA Polymerase Beta. Biol. Pharm. Bull., 1998; 21(5): 444-448. 364. Mizushina Y., et al., A Mushroom Fruiting Body-inducing Substance Inhibits Activities of Replicative DNA Polymerases. Biochem. Biophys. Res. Commun., 1998; 249(1): 17-22. 365. Mizushina Y., et al., Lucidenic Acid O and Lactone, New Terpene Inhibitors of Eukaryotic DNA Polymerases from a Basidiomycete, Ganoderma lucidum. Bioorg. Med. Chem., 1999; 7(9): 2047-2052. 366. Mori K., et al., Antitumor Activities of Edible Mushrooms by Oral Administration. P. J. Wuest, et al., ed., Cultivating Edible Fungi. Elsevier, 1987; 1-6. 367. Morigawa A., et al., Angiotensin Converting Enzyme-Inhibitory Triterpines from Ganoderma lucidum. Chem. Pharm. Bull, 1986; 34(7): 3025-3028. 368. Morishige F., et al., The Role of Vitamin C in Tumor Therapy (Human). Vitamins and Cancer: Human Cancer Prevention by Vitamins and Micronutrients. Frank L. Meyskens, Jr. and Kedar N. Prasad ed., Humana Press, New Jersey, 1986; 399-427. 369. Morishige F., In Becoming Healty with Reishi, III. Kampo I-Yaku Shimbun, Toyo-Igaku Sha co., Ltd., Tokyo, 1988; 12-20. 370. Morishige F., Reishi: Positive Cancer Treatments. Chin. Trad. Med. Part III, Page 12 – 23, ISBN4-88580-053-6 C-0077. 371. Mowrey D. B., Guaranteed Potency Herbs: Next Generation Herbal Medicine. Cormorant Books, Lehi, Utah, 1988. 372. Muirhead D. Y., Cudkowicz G., Subpopulations of Splenic T Cells Regulating an Anti-Hapten Antibody Response. I. Helper and Amplifier Cells. J. Immunol., 1978; 120(2): 579-585. 373. Murasugi A., et al., Molecular Cloning of a cDNA and a Gene Encoding an Immunomodulatory Protein, Ling Zhi-8, from Fungus, Ganoderma lucidum. J. Biol. Chem., 1991; 266(4): 2486-2493. 374. Naeshiro H., et al., Skin-lightening Compositions Containing Ganoderma Extract. Jap. Pat 04 09,315, 1992; CA 116: 158605z. 375. Naeshiro H., et al., Skin-lightening Cosmetics Containing Ganoderma lucidum and Vitamins. Jap. Pat 04 09,325, 1992; CA 116: 158610x.. 376. Nakashima S., et al., Effects of Polysaccharides from Ganoderma applanatum on Immune Responses. I. Enhancing Effect on the Induction of Delayed Hypersensitivity in Mice. Microbiology and Immunology, 1979; 23(6): 501-513. 377. Namba T., et al., Studies on Dental Caries Prevention by Traditional Chinese Medicines. Part I. Screening of Crude Drugs for Antibacterial Action against Streptococcus Mutans. Shoyakugaku Zasshi, 1981; 35: 295-302.
378. Nanjing Branch of the National Medical Society, Association of Heart Vessels Disease and No. 6 Department of Hunan Institute of Oharmaceutical Industry, Clinical Observations on the treatment of 103 Cases of Coronary Heart Disease with Ganoderma Shu Xin tablets. Chinese Traditional and Herbal Drugs, 1979; (6): 32-33. 379. Naoi Y., Artificial Cultivation of „Reishi”: To Harvest the High-quality Ganoderma lucidum. The 1st International Symposium on Ganoderma lucidum in Japan, Tokyo, November 17-18, 1997, Lecture 15. 380. Needham J., Science and Civilization in China. Vol. 5, Part II. Cambridge University Press, 1974; 114-123; Part V, 1983; 33. 381. Ning J., et al., Synthesis of Beta-(1-6)-branched beta-(1-3) glucohexaose and its Analogues Containing an Alpha-(1-3) Linked Bond with Antitumor Activity. Bioorg. Med. Chem., 2003; 11(10): 2193-2203. 382. Nishida R., et al., A Sclerosant with Astringent Properties Developed in China for Oesophageal Varces: Comparison with Ethanolamine Oleate and Polidocanol. J. Gastroenterol. Hepatol., 1999; 14(5): 481-488. 383. Nishitoba T., at al., New Terpenoids, Ganulucidic Acid D, Ganoderic Acid L, Lucidone C and Lucidenic Acid G, from the Fungus Ganoderma lucidum. Agric. Biol. Chem., 1986; 50:809-811. 384. Nishitoba T., et al., Novel Mycellial Components, Ganoderic Acid Mg, Mh, Mi, Mj and Mk, from the Fungus Ganoderma lucidum. Agr. Biol. Chem., 1987; 51(4): 1149-1153. 385. Nishitoba T., et al., Bitter Triterpenoids from the Fungus Ganoderma Applanatum. Phytochemistry, 1989; 28: 193-197. 386. Nogami M., et al., Studies on Genoderma lucidum. VI. Anti-allergic Effect. (1). Yakugaku Zasshi, 1986; 106(7): 594-599. 387. Nogami M., et al., Studies on Genoderma lucidum. VII. Anti-allergic Effect. (2). Yakugaku Zasshi, 1986; 106(7): 600-604. 388. Ody P., The Complete Medicinal Herbal. Darling Kinderslay, 1993; 178. 389. Oh K. W., et al., Antiherpetic Activities of Acid Protein Bound Polysaccharide Isolated from Ganoderma lucidum Alone and in Combination with Acyclovir and Vidarabine. J. Ethnopharmacol., 2000; 72(1-2): 221-227. 390. O’Neil C. E., et al., Basidiospore Extracts: Evidence for Common Antigenic/Allergenic Determinants. Int. Arch. Allergy Appl. Immunol., 1988; 85(2): 161-166. 391. Ooi L. S., et al., Gene Expression of Immunomodulatory Cytokine Induced by Narcissus tazetta Lectin in the Mouse. Biochem. Cell. Biol., 2002; 80(2): 271-277. 392. Park E. J., et al., Antifibrotic Effects of a Polysaccharide Extracted from Ganoderma lucidum, Glycyrrhizin, and Pentoxifylline in Rats with Cirrhosis Induced by Biliary Obstruction. Biol. Pharm Bull., 1997; 20(4): 417-420. Erratum in: Biol. Pharm. Bull., 1998; 21(6): 649. 393. Patocka J., Anti-inflammatory Triterpinoids from Mysterious Mushroom Ganoderma lucidum and their Potential Possibility in Modern Medicine. Acta Medica (Hradec Kralove), 1999; 42(4): 123-125
394. Pearson V., Chan T. W., The Relationship Between Parenting Stress and Social Support in Mothers of Children with Learning Disabilities: a Chinese Experience. Soc. Sci. Med., 1993; 37(2): 267-274. 395. Peng Y., et al., Anti-Lipid Peroxidative Effects of Ling Zhi in Mice. S. Zhu, M. Mori eds., The Research on Ganoderma lucidum (part one), Shanghai Medical University Press, Shanghai, 1993. 396. Pengelly A., Medicinal fungi of the world. Modern Phytotherapist 1996; 2:1, 3–8 397. Phanuphak P., Clinical Study of Micronized Reishi Mushroom in Thai HIV Patients. The 1st International Symposium on Ganoderma lucidum in Japan, Tokyo, November 17-18, 1997, Lecture 5. 398. Piaskowski S., Preliminary Studies on the Preparation and Application of Preparations from Black Birch Touchwood in Human Cases of Malignat Tumors. Sylwan, 1957; 101(10): 5-11. 399. Porterfield H., UsToo PC-SPES Surveys: Review of Studies and Update of Previous Survey Results. Mol. Urol., 2000; 4(3): 289-291.; Discussion 293. 400. Protiva J, et al., Triterpenes and Steroids from Ganoderma applantum. Coll. Czech. Chem. Comm., 1980; 45(10): 2710-2713. 401. Qi J.J., et al., Analysis of Generic Variation in Genoderma lucidum after Space Flight. Adv. Space Res., 2003; 31(6): 1617-1622. 402. Qui G., Wy A., Chinese Materia Medica with Anti-atopic Effect. Abstr. Chin. Med., 1986; 1: 119. 403. Raicht R. F., et al., Protective Effect of Plant Sterols againt Chemically Induced Colon Tumors in Rats. Cancer Res., 1980; 40: 403-405. 404. Reynolds J. E. F. ed., Martindale, The Extra Pharmacopoeia, 30 th. Ed. The Pharmaceutical Press, London, 1993. 405. Ripperger H., Budzikiewicz H., Phytochemical Reports: Steroide aus Ganoderma applanatum. Phytochemistry, 1975; 14: 2297-2298. 406. Riu H, et al., Production of Carpophores of Lentinus edodes and Ganoderma lucidum Grown on Cork Residues. Microbiologia, 1997; 13(2): 185-192. 407. Robbins R. C., Effects of Flavonoids on Survival Time of Rats fed Thrombogenic or Atherogenic Regiments. J. Atherosclerosis Res., 1967; 7: 3-10. 408. Robbins R. C., Effects of Phenyl Benzo-Gamma-Pyrone Derivatives (Flavonoids) on Blood Cell Aggregation: Basis for a Concept of Mode of Action. Clin. Chemistry, 1971; 17(5): 433-437. 409. Rossi E. L., The Psychobiology of Mind-Body Healing. W. W. Norto, Inc., 1986; 112-113. 410. Ryong L. R., et al.,Antiatherogenic and Antiatherosclerotic Effects of Mushroom Extracts Revealed in Human Intima Cell Culture. Drug Res. Develop., 1989; 17:109-117. 411. Sahley B. J., Reishi Mushroom, Healing Herb of the Future. MMRC Health Educator Reports, January 31, 1997; 1-2. 412. Saphir D., Neuropsychological and Endocrine Consequences of Immune Activity. Psychoneuroimmunology, 1989; 14(1/2): 63-87.
413. Sasaki T., et al., Antitumor Polysaccharides from Some Polyporaceae, Ganoderma appalnatum (Pers.) pat. and Phellinus linteus (Berk. and Curt.) Aoshima. Chem. Pharm. Bull., 1971; 19(4): 821-826. 414. Sato H., et al., Genoderiol A and B, New Triterpenoids from Fungus Ganoderma lucidum (Reishi). Agric. Biol. Chem., 1986; 50: 2887-2890. 415. Scheinholtz D., Immortality Mushrooms. Longevity, October, 1989. 416. Seo G. S., Kirk P. M., Ganodermataceae: Nomenclature and Classification. Ganoderma Diseases of Perennial Crops. J. Flood, et al., eds., CAB International, 2000. 417. Shan Y., et al., Diagnosis and Treatment of Spinal Cord Cavernous Angioma. Zhonghua Wai Ke Za Zhi, 2002; 40(4): 287-289. 418. Shi Y. L., et al., Mushroom-derived Preparations in the Prevention of H2O2 – induced Oxidative Damage to Cellular DNA. Teratog. Carcinog. Mutagen., 2002; 22(2): 103-111. 419. Shiao M. S., et al., Two New Triterpines of the Fungus Ganoderma lucidum. J. Nat. Prod., 1987; 50(5): 886-890. 420. Shia M. S., et al., Structures, Biosynthesis, and Biological Functions of Oxygenated Triterpenoids in Ganoderma lucidum. C. H. Chu, G. R. Waller, eds., Phytochemical Ecology: Allelochemicals, Mycotoxins and Insect Pheromones and Allomones, Institute od Botany, Academia Sinica Monograph Series No. 9, Taipei, 1989; 235-243. 421. Shiao M-S., et al., Natural Products and Biological Activities of the Chinese Medicinal Fungus Ganoderma lucidum. Food Phytochemicals II: Teas, Spices, and Herbs, Amer. Chem. Soc., 1994; 342-354. 422. Shiao M-S., Natural Products of the Medicinal Fungus Ganoderma lucidum: Occurance, Biological Activities, and Pharmacological Functions. Chem. Rec., 2003; 3(3): 172-180. 423. Shibata S., et al., List of Fungal Products. University of Tokyo Press, Tokyo, 1964. 424. Shibata S., et al., Antitumor Studies on Some Extracts of Basidiomycetes. Jap. J. Cancer Res., 1968; 59(2): 159-161. 425. Shieh Y. H., et al., Evaluation of the Hepatic and Renal-protective Effects of Ganoderma lucidum in Mice. Am. J. Chin. Med., 2001; 29(3-4): 501-507. 426. Shigeno T., Complex Medicine (Zenkisei Igaku), a System of Healing Heart, Brain and Body. The 1st International Symposium on Ganoderma lucidum in Japan, Tokyo, November 17-18, 1997, Lecture 9. 427. Shimbun K. I-Y., Becoming Healthy with Reishi. Sha Co. Ltd., Tokyo, 1988; 12-20. 428. Shimizu A., et al., Isolation of an Inhibitor of Platelet Aggregation from a Fungus, Ganoderma lucidum. Chem. Pharm. Bull., 1985; 33(7): 3012-3015. 429. Shin H-W, et al., Studies on Constituents of Higher Fungi of Korea. Part XLIII. Studies on Inorganic Composition and Immunopotentiating Activity of Ganoderma lucidum in Korea. Saengyak Hakhoechi, 1986; 16(4): 181-190; CA. 105: 29874k.